ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1960

Combination Of Magnetic Resonance Imaging-Proven Osteitis With 2010 RA Classification Criteria Improves The Diagnostic Probability Of Early Rheumatoid Arthritis Whose Disease Duration Less Than 6 Months

Mami Tamai1,2, Junko Kita3, Yoshikazu Nakashima4, Ayako Nishino4, Takahisa Suzuki4, Yoshiro Horai4, Akitomo Okada5, Tomohiro Koga6, Shin-ya Kawashiri4,7, Naoki Iwamoto4, Kunihiro Ichinose4, Kazuhiko Arima7, Satoshi Yamasaki8, Hideki Nakamura4, Tomoki Origuchi9, Masataka Uetani10, Aya Fukushima10, Kiyoshi Aoyagi7, Katsumi Eguchi11 and Atsushi Kawakami4, 1Center for Health & Community Medicine, Nagasaki University, Nagasaki, Japan, 2Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 4Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan, 6Departments of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 7Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 8Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 9Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 10Department of Radiology and Radiation Research, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 11Sasebo City General Hospital, Sasebo, Nagasaki, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, MRI and diagnostic criteria

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

In the articles describing the 2010 rheumatoid arthritis (RA) classification criteria , it is stated that additional evidence of joint injury from imaging techniques such as magnetic resonance imaging (MRI) may be used for confirmation of the clinical findings. MRI is able to detect synovitis, tenosynovitis, osteitis and bone erosion. Among these, osteitis, is supposed to be the best surrogate MRI feature for differentiating RA from other rheumatic diseases. This study is undertaken to investigate whether MRI-proven osteitis improves the diagnostic performance of the 2010 RA classification criteria among early arthritis patients.

Methods:

All of early arthritis patients, whose disease duration at entry less than 6 months, were recruited in the present study from Nagasaki University Early Arthritis Cohort. Patients whose diagnoses were compatible with rheumatic diseases other than RA or obvious to plain radiographic erosion at entry, were excluded. All of the subjects underwent physical examination, blood tests, and gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI on the same day. Gold-standard RA was defined as the patients receiving disease-modifying antirheumatic drugs during the first year. The diagnostic performance of the 2010 RA criteria with or without the finding of MRI-proven joint injury was investigated.

Results:

One hundred sixty-four patients, whose median disease duration at entry was 2 months, were recruited. The median values for age, CRP (mg/l), prevalence of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) at examination were 54 years, 2.0, 40.2% and 34.1%, respectively. The 2010 RA classification criteria classified RA with a sensitivity of 62.4%, a specificity of 83.1%, a positive predictive value (PPV) of 82.9%, a negative predictive value (NPV) of 62.8%, accuracy of 71.3%. Osteitis was the most specific MRI finding in gold-standard RA . We have proposed a decision-tree algorithm that involves initially applying the 2010 RA classification criteria, and if the patients do not fulfill 2010 RA classification criteria, the MRI-proven osteitis rule is introduced. The tree algorithm has been shown to differentiate patients more efficiently than the 2010 RA classification criteria alone, exhibiting a sensitivity of 79.6%, a specificity of 76.1%, a PPV of 81.3%, a NPV of 74.0%, accuracy of 78.0%.

Conclusion:

The present data indicate that the combination of MRI-proven osteitis with the 2010 RA classification criteria improves the diagnostic probability of RA at an early stage.


Disclosure:

M. Tamai,
None;

J. Kita,
None;

Y. Nakashima,
None;

A. Nishino,
None;

T. Suzuki,
None;

Y. Horai,
None;

A. Okada,
None;

T. Koga,
None;

S. Y. Kawashiri,
None;

N. Iwamoto,
None;

K. Ichinose,
None;

K. Arima,
None;

S. Yamasaki,
None;

H. Nakamura,
None;

T. Origuchi,
None;

M. Uetani,
None;

A. Fukushima,
None;

K. Aoyagi,
None;

K. Eguchi,

UCB Pharma,

5;

A. Kawakami,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/combination-of-magnetic-resonance-imaging-proven-osteitis-with-2010-ra-classification-criteria-improves-the-diagnostic-probability-of-early-rheumatoid-arthritis-whose-disease-duration-less-than-6-mont/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology